The harmfulness of benign prostatic hyperplasia lies in the pathological and physiological changes caused by lower urinary tract obstruction. The pathological individual differences are very large, and not all show progressive development. Some lesions stop developing at a certain degree, so even if there are mild obstruction symptoms, not all require surgery.
One, Watch and Wait
For mild symptoms, those with an IPSS score of 7 points or less can be observed without treatment.
Two, Medication Treatment
1. Research on 5α-reductase inhibitors has found that 5α-reductase is an important enzyme for the conversion of testosterone to dihydrotestosterone. Dihydrotestosterone plays a certain role in benign prostatic hyperplasia, so the use of 5α-reductase inhibitors can provide certain inhibition of hyperplasia.
2. Alpha-adrenergic blockers are currently believed to improve urinary tract dynamic obstruction, reduce resistance to improve symptoms, and commonly used drugs include Gao Deting, etc.
3. The most widely used anti-androgen drugs are progestin drugs. They can inhibit the cell binding and nuclear uptake of androgens, or inhibit 5α-reductase to interfere with the formation of dihydrotestosterone.
Three, Surgical Treatment
Surgery is still an important treatment method for benign prostatic hyperplasia. For patients with long-term urinary tract obstruction, obvious renal function damage, severe urinary tract infection, or acute urinary retention, it is necessary to first insert a urinary catheter to relieve obstruction, wait for the infection to be controlled, and then perform surgery after renal function recovery. If it is difficult to insert a urinary catheter or the catheter insertion time is long, leading to urethritis, it can be changed to suprapubic bladder puncture and stenting. The indications for emergency prostatectomy should be strictly controlled.
Four, Minimally Invasive Treatment
1. Transurethral prostate electrovaporization is mainly an innovation in electrode metal materials.
2. Transurethral prostate plasma bipolar resection and transurethral plasma prostate enucleation are surgical procedures using a plasma bipolar resection system and performed in a manner similar to monopolar TURP to perform transurethral prostatectomy.
3. Cryotherapy is to cause the prostate to necrotic and desquamate after deep hypothermic freezing, thus achieving the purpose of cryoablation of the prostate.
4. Microwave therapy utilizes the thermal coagulation principle of microwave on biological tissue to achieve therapeutic purposes. The placement of microwave emitting electrodes can be located by rectal ultrasound or under direct vision of the urethroscope. The latter can accurately avoid the external sphincter of the urethra, reducing the incidence of complications such as urinary incontinence.
5. Laser therapy utilizes the thermal effect of laser to coagulate, vaporize, or excise prostate tissue, with a method similar to transurethral endoscopic manipulation.
6. Radiofrequency ablation uses radiofrequency waves to produce local thermal effects to cause coagulative necrosis of the prostate tissue.